Loading…
Solesence, Inc. is projected to rise to $0.8611 by 2027, a +4% move from its current price of $0.9901. SLSN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9266 | $0.9884 | $1.05 | -0.17% |
| Aug 6 | $0.9006 | $0.9868 | $1.08 | -0.34% |
| Aug 7 | $0.8808 | $0.9851 | $1.10 | -0.51% |
| Aug 8 | $0.8642 | $0.9834 | $1.12 | -0.67% |
| Aug 9 | $0.8497 | $0.9818 | $1.13 | -0.84% |
| Aug 10 | $0.8367 | $0.9801 | $1.15 | -1.01% |
| Aug 11 | $0.8247 | $0.9785 | $1.16 | -1.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8247 | $0.9785 | $1.16 | -1.18% |
| Week 2 | $0.7593 | $0.967 | $1.23 | -2.34% |
| Week 3 | $0.7107 | $0.9556 | $1.28 | -3.49% |
| Week 4 | $0.6709 | $0.9443 | $1.33 | -4.62% |
| Week 5 | $0.6368 | $0.9332 | $1.37 | -5.74% |
| Week 6 | $0.6068 | $0.9223 | $1.40 | -6.85% |
| Week 7 | $0.5799 | $0.9114 | $1.43 | -7.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Solesence, Inc. is a consumer defensive company that provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company manufactures surface engineered zinc oxide and titanium dioxide ingredients and offers skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients, as well as skin health products such as sunscreens and daily care products.
It serves multiple markets including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications, supporting skin health, beauty, and wellness.
Formerly Nanophase Technologies Corporation, the company changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois. It is categorized in the Consumer Defensive sector.
Solesence, Inc. (SLSN) is the consumer defensive stock behind engineered zinc oxide and titanium dioxide ingredients and skin care formulations with mineral-based UV protection. The stock currently trades at $0.82 and has a market cap of $57.92M, ranking 4223rd by market capitalization.
The near-term technical picture shows a neutral stance, with RSI (14) at 50, and moving averages at $1.03 (SMA50) and $1.57 (SMA200). The stock sits on a support level of $0.64 and faces resistance at $1.34, with a 30-day trading range from $0.5288 to $1.27. Annualized volatility is high at 100%, underscoring elevated risk.
Longer-term forecasts indicate meaningful upside, with 2030 averaging $1.31 and a bullish sentiment, 2040 averaging $2.20 with a 168.3 ROI, and 2050 averaging $5.36 with a 554.2 ROI. These projections imply a trajectory of substantial appreciation over the next decade and beyond, albeit with inherent uncertainty.
A major floor 76.1% below — a decisive break under it would weaken the trend.
The nearest floor, 35.4% below — buyers have tended to step in here.
The nearest ceiling, 35.3% above — a clean break opens room to run.
A major ceiling 65.3% above — clearing it would confirm fresh momentum.
Key SLSN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLSN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.884 | Buy | $0.8644 | Buy |
| MA 10 | $0.871 | Buy | $0.8602 | Buy |
| MA 20 | $0.797 | Buy | $0.8655 | Buy |
| MA 50 | $1.03 | Sell | $0.9718 | Buy |
| MA 100 | $1.09 | Sell | $1.15 | Sell |
| MA 200 | $1.56 | Sell | $1.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.88 | Neutral |
| Stoch RSI (14) | 61.45 | Neutral |
| CCI (20) | 25.37 | Neutral |
| Williams %R (14) | -47.22 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 52.78 | Neutral |
| TRIX (15) | -0.91 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 48.94 | Neutral |
| Momentum (10) | 0.05 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.86 | Buy |
| ADX (14) | 15.61 | Neutral |
| ATR (14) | 0.05 | Info |
Near term, the sentiment is NEUTRAL with RSI 14 at 50. The SMA readings show SMA50 at $1.03 and SMA200 at $1.57, illustrating a mixed trend against a current price of $0.82. Support is identified at $0.64 and resistance at $1.34, with the 30-day range spanning $0.5288 to $1.27.
The setup suggests potential range-bound activity in the short term, with elevated volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.64 | $0.8303 | $1.15 | 0% | Neutral | |
| $0.6274 | $0.8611 | $1.28 | +4% | Neutral | |
| $0.9612 | $1.40 | $2.22 | +69% | Bullish | |
| $1.01 | $1.55 | $2.57 | +86% | Bullish | |
| $0.834 | $1.35 | $2.33 | +62% | Bullish | |
| $0.8964 | $1.51 | $2.71 | +82% | Bullish | |
| $0.7819 | $1.38 | $2.54 | +66% | Bullish | |
| $0.7332 | $1.34 | $2.55 | +62% | Bullish | |
| $0.9449 | $1.80 | $3.51 | +117% | Bullish | |
| $1.04 | $2.05 | $4.09 | +147% | Bullish | |
| $1.03 | $2.29 | $5.03 | +176% | Bullish | |
| $2.56 | $5.68 | $13.07 | +584% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.64 | $0.8303 | $1.07 | -16.14% |
| September 2026 | $0.6845 | $0.8324 | $1.06 | +0.25% |
| October 2026 | $0.6883 | $0.8487 | $1.10 | +1.96% |
| November 2026 | $0.7222 | $0.9006 | $1.19 | +6.12% |
| December 2026 | $0.6851 | $0.8633 | $1.15 | -4.14% |
Click any year to see its month-by-month SLSN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Solesence, Inc.'s 2026 outlook centres on $0.8303, within a $0.64 to $1.15 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SLSN could reach as high as $1.28, with a base case around $0.8611 and support toward $0.6274 — roughly +4% from $0.9901. Price action looks broadly range-bound.
Expect SLSN to range from $0.9612 to $2.22 through 2028. The $1.40 average target implies a +69% move from current prices. That is up +63% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The SLSN price prediction for 2029 points to an average of $1.55 (low $1.01, high $2.57) — a potential gain of +86% on today's $0.9901. Momentum favours further upside here.
In 2030, SLSN is projected to trade between $0.834 and $2.33, averaging $1.35 — a potential gain of +62% from today's $0.9901. That is -13% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Solesence, Inc.'s 2031 outlook centres on $1.51, within a $0.8964 to $2.71 range. That is up +12% on the projected 2030 average. That marks a +82% change versus current levels. Momentum favours further upside here.
By 2032, SLSN could reach as high as $2.54, with a base case around $1.38 and support toward $0.7819 — roughly +66% from $0.9901. Buyers look set to stay in control over this stretch.
Expect SLSN to range from $0.7332 to $2.55 through 2033. The $1.34 average target implies a +62% move from current prices. That is -2% versus the projected 2032 average. Momentum favours further upside here.
The SLSN price prediction for 2034 points to an average of $1.80 (low $0.9449, high $3.51) — a potential gain of +117% on today's $0.9901. Buyers look set to stay in control over this stretch.
In 2035, SLSN is projected to trade between $1.04 and $4.09, averaging $2.05 — a potential gain of +147% from today's $0.9901. That is up +14% on the projected 2034 average. Momentum favours further upside here.
Solesence, Inc.'s 2040 outlook centres on $2.29, within a $1.03 to $5.03 range. That is up +12% on the projected 2035 average. That marks a +176% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SLSN could reach as high as $13.07, with a base case around $5.68 and support toward $2.56 — roughly +584% from $0.9901. Momentum favours further upside here.
Investing $1,000 in SLSN today (≈ 1,009.99899 SLSN) could be worth
$5,739.02
+$4,739.02 (+474%) by 2050 · US Dollar
Based on the average projected SLSN price of $5.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLSNwould be worth at today's price.
$1,000 invested in SLSN on Jul 31, 2025 (≈ 291.545184 SLSN) would be worth
$288.66
-$711.34 (-71.1%) today · 0.29× · US Dollar
Based on a SLSN entry price of $3.43 vs. today's $0.9901.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.94 | $1,053.3 | +5.3% |
| 1 month ago | $0.73 | $1,356.3 | +35.6% |
| 3 months ago | $1.34 | $738.88 | -26.1% |
| 6 months ago | $1.48 | $668.99 | -33.1% |
| 1 year ago | $3.43 | $288.66 | -71.1% |
| All time (5.0y) ago | $2.47 | $400.85 | -59.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLSN forecast.
Our base-case forecast reaches $2.00 around 2035.
Implied market cap at $2.00: $141.26M
Over the multi-year horizon, the forecast depicts a bullish trajectory. For 2026, the min/max/avg are $0.64/$1.13, $0.82 respectively with ROI 0 and NEUTRAL sentiment; 2027 shows min $0.6151, avg $0.8447, max $1.25 with ROI 3 and NEUTRAL sentiment. The bullish momentum accelerates in later years, with 2028 avg $1.37 and 2029 avg $1.50, followed by 2030 avg $1.31 with ROI 59.7 and BULLISH sentiment.
In 2031, 2032, and 2033 the averages are $1.47, $1.33, and $1.29 respectively, all bearing bullish sentiment, with ROI values of 79.6, 61.7, and 57.9. The forecast then shows 2034 avg $1.73 (ROI 110.7) and 2035 avg $1.96 (ROI 138.7), continuing the bullish tone.
Crucially, the long-range outlook highlights 2040 average $2.20 (ROI 168.3) and 2050 average $5.36 (ROI 554.2), both labeled BULLISH. The 2040 and 2050 figures illustrate substantial longer-term upside potential, while the 2050 max is projected as $12.34. These numbers suggest significant appreciation over time, but they are not guarantees and depend on a range of factors that can influence outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.31 with a min of $0.8115 and a max of $2.27, and an ROI of 59.7. The sentiment is BULLISH.
The forecast reflects a shift to a BULLISH sentiment in 2028 and beyond, with 2030 avg $1.31 (ROI 59.7), 2040 avg $2.20 (ROI 168.3), and 2050 avg $5.36 (ROI 554.2). Near-term years 2026–2027 are NEUTRAL.
Yes, the forecast envisions potential price paths including a 2028 max of $2.17 and a 2030 max of $2.27, with higher peaks expected later (2040 max $4.83 and 2050 max $12.34).
Current price is $0.82 and market cap is $57.92M. The stock ranks 4223 by market capitalization.
The 30-day range is $0.5288 to $1.27, with RSI 14 at 50, SMA50 at $1.03, SMA200 at $1.57, support at $0.64, and resistance at $1.34. The annualized volatility is 100%, and the sentiment is NEUTRAL.
Solesence, Inc. Community Discussion
0Share your Solesence, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.